336 related articles for article (PubMed ID: 26595384)
1. Transient PLK4 overexpression accelerates tumorigenesis in p53-deficient epidermis.
Serçin Ö; Larsimont JC; Karambelas AE; Marthiens V; Moers V; Boeckx B; Le Mercier M; Lambrechts D; Basto R; Blanpain C
Nat Cell Biol; 2016 Jan; 18(1):100-10. PubMed ID: 26595384
[TBL] [Abstract][Full Text] [Related]
2. Chronic centrosome amplification without tumorigenesis.
Vitre B; Holland AJ; Kulukian A; Shoshani O; Hirai M; Wang Y; Maldonado M; Cho T; Boubaker J; Swing DA; Tessarollo L; Evans SM; Fuchs E; Cleveland DW
Proc Natl Acad Sci U S A; 2015 Nov; 112(46):E6321-30. PubMed ID: 26578792
[TBL] [Abstract][Full Text] [Related]
3. Epidermal development, growth control, and homeostasis in the face of centrosome amplification.
Kulukian A; Holland AJ; Vitre B; Naik S; Cleveland DW; Fuchs E
Proc Natl Acad Sci U S A; 2015 Nov; 112(46):E6311-20. PubMed ID: 26578791
[TBL] [Abstract][Full Text] [Related]
4. Centrosome Amplification Is Sufficient to Promote Spontaneous Tumorigenesis in Mammals.
Levine MS; Bakker B; Boeckx B; Moyett J; Lu J; Vitre B; Spierings DC; Lansdorp PM; Cleveland DW; Lambrechts D; Foijer F; Holland AJ
Dev Cell; 2017 Feb; 40(3):313-322.e5. PubMed ID: 28132847
[TBL] [Abstract][Full Text] [Related]
5. Over-expression of Plk4 induces centrosome amplification, loss of primary cilia and associated tissue hyperplasia in the mouse.
Coelho PA; Bury L; Shahbazi MN; Liakath-Ali K; Tate PH; Wormald S; Hindley CJ; Huch M; Archer J; Skarnes WC; Zernicka-Goetz M; Glover DM
Open Biol; 2015 Dec; 5(12):150209. PubMed ID: 26701933
[TBL] [Abstract][Full Text] [Related]
6. PLK4: a promising target for cancer therapy.
Zhao Y; Wang X
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2413-2422. PubMed ID: 31492983
[TBL] [Abstract][Full Text] [Related]
7. SAPK pathways and p53 cooperatively regulate PLK4 activity and centrosome integrity under stress.
Nakamura T; Saito H; Takekawa M
Nat Commun; 2013; 4():1775. PubMed ID: 23653187
[TBL] [Abstract][Full Text] [Related]
8. Loss of KLF14 triggers centrosome amplification and tumorigenesis.
Fan G; Sun L; Shan P; Zhang X; Huan J; Zhang X; Li D; Wang T; Wei T; Zhang X; Gu X; Yao L; Xuan Y; Hou Z; Cui Y; Cao L; Li X; Zhang S; Wang C
Nat Commun; 2015 Oct; 6():8450. PubMed ID: 26439168
[TBL] [Abstract][Full Text] [Related]
9. Polo-like kinase 4 kinase activity limits centrosome overduplication by autoregulating its own stability.
Holland AJ; Lan W; Niessen S; Hoover H; Cleveland DW
J Cell Biol; 2010 Jan; 188(2):191-8. PubMed ID: 20100909
[TBL] [Abstract][Full Text] [Related]
10. Cyclin B2 and p53 control proper timing of centrosome separation.
Nam HJ; van Deursen JM
Nat Cell Biol; 2014 Jun; 16(6):538-49. PubMed ID: 24776885
[TBL] [Abstract][Full Text] [Related]
11. ECRG2 disruption leads to centrosome amplification and spindle checkpoint defects contributing chromosome instability.
Cheng X; Shen Z; Yang J; Lu SH; Cui Y
J Biol Chem; 2008 Feb; 283(9):5888-98. PubMed ID: 18162463
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous Aurora-A/STK15 overexpression and centrosome amplification induce chromosomal instability in tumour cells with a MIN phenotype.
Lentini L; Amato A; Schillaci T; Di Leonardo A
BMC Cancer; 2007 Nov; 7():212. PubMed ID: 17999753
[TBL] [Abstract][Full Text] [Related]
13. Centrosome amplification in tumorigenesis.
Anderhub SJ; Krämer A; Maier B
Cancer Lett; 2012 Sep; 322(1):8-17. PubMed ID: 22342684
[TBL] [Abstract][Full Text] [Related]
14. Centrosome amplification and overexpression of aurora A are early events in rat mammary carcinogenesis.
Goepfert TM; Adigun YE; Zhong L; Gay J; Medina D; Brinkley WR
Cancer Res; 2002 Jul; 62(14):4115-22. PubMed ID: 12124350
[TBL] [Abstract][Full Text] [Related]
15. Cep131 overexpression promotes centrosome amplification and colon cancer progression by regulating Plk4 stability.
Kim DH; Ahn JS; Han HJ; Kim HM; Hwang J; Lee KH; Cha-Molstad H; Ryoo IJ; Jang JH; Ko SK; Yang JO; Lee HG; Lee S; Song EJ; Kim JY; Huh YH; Kwon YT; Soung NK; Kim BY
Cell Death Dis; 2019 Jul; 10(8):570. PubMed ID: 31358734
[TBL] [Abstract][Full Text] [Related]
16. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation.
Zhou H; Kuang J; Zhong L; Kuo WL; Gray JW; Sahin A; Brinkley BR; Sen S
Nat Genet; 1998 Oct; 20(2):189-93. PubMed ID: 9771714
[TBL] [Abstract][Full Text] [Related]
17. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells.
Meraldi P; Honda R; Nigg EA
EMBO J; 2002 Feb; 21(4):483-92. PubMed ID: 11847097
[TBL] [Abstract][Full Text] [Related]
18. An inducible mouse model for skin cancer reveals distinct roles for gain- and loss-of-function p53 mutations.
Caulin C; Nguyen T; Lang GA; Goepfert TM; Brinkley BR; Cai WW; Lozano G; Roop DR
J Clin Invest; 2007 Jul; 117(7):1893-901. PubMed ID: 17607363
[TBL] [Abstract][Full Text] [Related]
19. Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis.
Wang XJ; Greenhalgh DA; Jiang A; He D; Zhong L; Medina D; Brinkley BR; Roop DR
Oncogene; 1998 Jul; 17(1):35-45. PubMed ID: 9671312
[TBL] [Abstract][Full Text] [Related]
20. Targeting the centrosome and polo-like kinase 4 in osteosarcoma.
Kelleher FC; Kroes J; Lewin J
Carcinogenesis; 2019 Jun; 40(4):493-499. PubMed ID: 30508038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
